scispace - formally typeset
E

Eri Iwai-Kanai

Researcher at Tenri Health Care University

Publications -  41
Citations -  2674

Eri Iwai-Kanai is an academic researcher from Tenri Health Care University. The author has contributed to research in topics: Myocyte & Apoptosis. The author has an hindex of 23, co-authored 41 publications receiving 2344 citations. Previous affiliations of Eri Iwai-Kanai include Kyoto Prefectural University & Meiji University of Integrative Medicine.

Papers
More filters
Journal ArticleDOI

Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart

TL;DR: It is shown that cytosolic p53 binds to Parkin and disturbs its translocation to damaged mitochondria and their subsequent clearance by mitophagy and overexpression of Parkin ameliorates the functional decline in aged hearts, and is accompanied by decreased senescence-associated β-galactosidase activity and proinflammatory phenotypes.
Journal ArticleDOI

A method to measure cardiac autophagic flux in vivo

TL;DR: A method to measure autophagic flux in vivo even in non-transgenic animals, using MDC and chloroquine is described, validating its use as a marker of autophagosomes.
Journal ArticleDOI

LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection.

TL;DR: The notion that autophagy is a cytoprotective response to LPS-induced cardiomyocyte injury is supported; additional studies are needed to determine the therapeutic implications.
Journal ArticleDOI

α- and β-Adrenergic Pathways Differentially Regulate Cell Type–Specific Apoptosis in Rat Cardiac Myocytes

TL;DR: C cultured neonatal rat cardiac myocytes were characterized by cell shrinkage and nuclear condensation, consistent with morphological features of apoptosis, and Iso and 8-Br-cAMP markedly increased the number of TUNEL-positive cells compared with saline stimulation.
Journal ArticleDOI

Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic β-cell function in diabetes

TL;DR: It is found that genetic and pharmacological inhibition of p53 preserves insulin secretion and glucose tolerance in both streptozotocin-induced type 1 and db/db mouse models of type 2 diabetes.